Panel Weighs Overhaul Of NSF's Grant System

An agency report suggests merit review revisions that would simplify proposals, extend grant duration, and give staff more autonomy WASHINGTON--A report of an in-house panel that examined peer review at the National Science Foundation proposes drastic remedies for what it says is an overburdened and inefficient system of selecting and awarding grants. Its recommendations--longer-term grants, more autonomy for program officers and less reliance on outside reviewers, fewer categories of grants,

Written byJeffrey Mervis
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

For Tulane University physicist John Perdew, the panel's suggestions would mean good riddance to what he believes is now a lottery among highly qualified proposals. For population biologist Robert Wyatt of the University of Georgia, they would mean a welcome reliance on a scientist's track record in reviewing and awarding grants. And for ecologist Garth Redfield, they offer the hope of improved working conditions for himself and his fellow program managers at NSF.

The report of the Merit Review Task Force, completed this past summer and then sent out to all grantees for comment, so far has attracted little attention. Yet the study has the potential of changing the way that NSF passes out money--nearly $2 billion this year--for scientific and educational research and training.

WASHINGTON--The National Science Foundation isn't the only federal research agency that's taking a fresh look at its peer review system. The National Institutes of Health ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies